Alastair Smith interview with Director’s Talk

Avacta’s Chief Executive Officer discusses the interim results

Alastair Smith joins DirectorsTalk to discuss interim results for the period ended 31st Jan 2019. Alastair talks through the LG Chem deal, shares his thoughts on the possibility of collaboration partner Moderna getting an Affimer drug to the clinic, the progress Avacta are making, why a collaboration with Tufts is key in its strategy and expands on a growing pipeline of revenue generating opportunities.

Avacta Group – A proven platform with significant upside from DirectorsTalk on Vimeo.